(Reuters) – Translate Bio Inc said on Tuesday that an experimental coronavirus vaccine it developed with French drugmaker Sanofi SA induced immune response in early-stage non-human primate studies.
In a regulatory filing https://www.sec.gov/ix?doc=/Archives/edgar/data/1693415/000119312520229383/d904716d8k.htm, the company cited Sanofi’s presentation slides showing that the vaccine candidate induced neutralizing antibodies and T-cell responses in animal studies.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Maju Samuel)
